357 results on '"Hirt S"'
Search Results
2. Herzentnahme zur Transplantation
3. Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial
4. Lung transplantation for acute pulmonary failure
5. Metabolic Tumor Volume for Outcome Prediction in Patients with Aggressive B-Cell Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
6. Allogene Stammzelltransplantation für Patienten über 70 Jahre
7. Das stumpfe Thoraxtrauma — Verletzungen von Herz und großen Gefäßen: 'Weniger, mehr — zu viel'
8. Fibrinkleber bei der Transplantation intrathorakaler Organe
9. Antagonisation of platelet activating factor — a new therapeutic concept for improvement of organ quality in lung preservation
10. Dangerous surgical scavenger hunt: the complicated course of a patient with left ventricular assist device and end-stage renal disease undergoing reconstructive flap surgery
11. A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP PHASE IV TRIAL INVESTIGATING THE OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY OF CNI-REDUCTION OR ELIMINATION WITH EVEROLIMUS IN DE NOVO HEART TRANSPLANT RECIPIENTS: THE MANDELA STUDY DESIGN: P107
12. THE COMBINATION OF EVEROLIMUS AND PIRFENIDONE SUPPRESSED THE DEVELOPMENT OF CHRONIC REJECTION AFTER RAT LUNG TRANSPLANTATION: P091
13. Joining of thermoplastic carbon fiber reinforced plastic laminates by selective heat input during laser cutting
14. Extrakorporaler Zementabfluss mit Füllung des extraduralen Venenplexus bis in die V. cava nach Vertebroplastie: Fallbericht und Aufarbeitung des Schrifttums
15. Inhibition of Innate Co-Receptor TREM-1 Signaling Reduces CD4+ T Cell Activation and Prolongs Cardiac Allograft Survival
16. Relevance of maintenance triple-drug immunosuppression to bridle the amplification of rat cytomegalovirus infection after experimental lung transplantation
17. Surgical technique and complications in lung transplantation
18. Computed chest tomography in an animal model for decompression sickness: radiologic, physiologic, and pathologic findings
19. Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study.: Abstract# 163
20. Effect of Everolimus Based Immunosuppression on De Novo Heart Transplant Recipients —24 Months Efficacy and Safety Results from A2310 Study.: Abstract# 140
21. Successful use of a percutaneous miniaturized extracorporeal life support system as a bridge and assistance to left ventricular assist device implantation in a patient with severe refractory cardiogenic shock
22. C1-esterase inhibitor in graft failure after lung transplantation
23. CMV INFECTIONS ARE LESS FREQUENT IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING IMMUNOSUPPRESSION WITH EVEROLIMUS PLUS REDUCED CSA COMPARED TO MMF AND STANDARD CSA: 036
24. EFFICACY AND RENAL FUNCTION IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH REDUCED CSA COMPARED TO MMF WITH STANDARD CSA: THE A2310 STUDY: 034
25. AN EXPERIMENTAL APPROACH TOWARD BRONCHIOLITIS OBLITERANS - VERIFICATION OF DIFFERENT IMMUNOSUPPRESSIVE STRATEGIES: 172
26. ADVERSE EVENTS ASSOCIATED WITH mTOR INHIBITION: RESULTS FROM THE A2310 STUDY COMPARING EVEROLIMUS AND MMF IN DE NOVO HEART TRANSPLANT RECIPIENTS: O-204
27. Abnormal P-waves found in patients with sleep-disordered breathing are associated with triggered pro-arrhythmic activity
28. Boundary Layer Flow Control by an Array of Ramp-Shaped Vortex Generators
29. Effects of ischaemia and preservation on the ultrastructure of the bronchiolar epithelium: A quantitative electron microscopic study of human and canine lungs
30. Thoracic organ transplantation in the paediatric age group: The Hannover experience
31. Surfactant replacement in reperfusion injury after clinical lung transplantation
32. Laser-based repair of carbon fiber reinforced polymers with polyamide 6 matrix material
33. Adhesion molecules in patients after lung transplantation
34. Coronary artery bypass surgery in the elderly: A comparison of minimized and conventional extracorporeal circulation
35. Invasive Rhizopus infection originating from the chest cavity post pneumonectomy
36. A Multi-Center, Randomized, Open-Label, Parallel Group Phase IV Trial Investigating the Outcome on Renal Function, Efficacy and Safety of CNI-Reduction or Elimination With Everolimus in De Novo Heart Transplant: Recipients: The MANDELA Study Design
37. Impact of Cardiac Troponin I as a Predictor of Graft Failure in Selection of Heart Donors
38. Improving Outcome of Coronary Artery Bypass Grafting in the Elderly by Using Minimized Extracorporeal Circulation
39. INCOR® INVASTOP - Reduction of Driveline Infection Rate: Observational Prospective Study of Silicone at the Driveline Exit Site
40. Dangerous surgical scavenger hunt: the complicated course of a patient with left ventricular assist device and end-stage renal disease undergoing reconstructive flap surgery
41. A comparison of cardiac troponin I and creatine kinase-MB for selection of heart donors and as predictors of graft failure
42. Total aortic replacement for extensive aneurysmal disease by staged hybrid procedure using E-vita open followed by percutaneous endovascular interventions
43. Adverse events associated with mTOR inhibition: Results from the A2310 study comparing everolimus and mmf in de novo heart transplant recipients
44. Slight exercise in ambulatory LVAD patients leads to a severe compromise of hemodynamic parameters
45. Impact of re-exploration for bleeding or tamponade on outcome after cardiac surgery
46. Emergency coronary artery bypass surgery using minimized extracorporeal circulation compared to conventional extracorporeal circulation
47. 24-Month Safety and Efficacy of Concentration Controlled Everolimus with Reduced Cyclosporine Versus Mycophenolate Mofetil in 721 De Novo Heart Transplant Recipients: Results from the A2310 Study
48. mTOR-Inhibitor-Attributed Events: Review of 2-Year Safety Data in Heart Transplant Recipients Receiving Everolimus Vs MMF in the Randomised Multi-Centre 2310 Study
49. 201 Multicenter Randomized Trial of Everolimus vs. Mycophenolate Mofetil in Heart Transplantation: Final 24 Month Analysis of Efficacy and Safety
50. 667 Development of Serum Lipids in Everolimus Treated Heart Recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.